S100B and Parkinson disease: Additionally, the S100B protein level was increased in the substantia nigra and cerebrospinal fluid of PD patients, and S100B was increased as well in the ventral midbrain of a mouse model treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (62).